Uterine Cancer pp 381-383 | Cite as

Surveillance of Uterine Sarcomas

  • Neha Kumar
  • Shalini Rajaram


Uterine sarcomas are uncommon tumors which constitute 3 % of all uterine malignancies [1]. They are aggressive tumors with a tendency for local and distant spread and hence have a guarded prognosis. These include leiomyosarcomas (LMS), endometrial stromal tumors (ESS), undifferentiated uterine sarcomas (UUS), and pure heterologous sarcomas. Mixed epithelial and mesenchymal tumors are adenosarcomas and carcinosarcomas.


National Comprehensive Cancer Network National Comprehensive Cancer Network Myometrial Invasion Uterine Sarcoma Endometrial Stromal Sarcoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    D’Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2010;116:131–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Major F, Blessing J, Silverberg S, Morrow C, Creasman W, Currie J, et al. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer. 1993;71 Suppl 4:1702–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Ramondetta LM, Bodurka DC, Deavers MT, Jhingran A. Uterine sarcomas. In: Eifel P, editor. Gynecologic cancer, M. D. Anderson cancer care series. New York: Springer; 2006. p. 125–47.CrossRefGoogle Scholar
  4. 4.
    Gadducci A. Prognostic factors in uterine sarcoma. Best Pract Res Clin Obstet Gynaecol. 2011;25:783–95.CrossRefPubMedGoogle Scholar
  5. 5.
    Tavassoli F, Deville P, editors. Pathology & genetics of the tumours of the breast and female genital organs. World Health Organization Classification of Tumours. Lyon: IARC Press; 2003. p. 233–6.Google Scholar
  6. 6.
    Gadducci A, Sartori E, Landoni F, et al. Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol. 1996;63:247–53.CrossRefPubMedGoogle Scholar
  7. 7.
    Gadducci A, Cosio S, Romanini A, et al. The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol. 2008;65:129–42.CrossRefPubMedGoogle Scholar
  8. 8.
    Trope CG, Abeler VM, Kristensen GB. Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncol. 2012;51:694–705.CrossRefPubMedGoogle Scholar
  9. 9.
    Kapp DS, Shin JY, Chan JK. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer. 2008;112:820–30.CrossRefPubMedGoogle Scholar
  10. 10.
    Blom R, Guerrieri C, Stâl O, et al. Leiomyosarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases. Gynecol Oncol. 1998;68:54–61.CrossRefPubMedGoogle Scholar
  11. 11.
    Mayerhofer K, Obermair A, Windbichler G, et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol. 1999;74:196–201.CrossRefPubMedGoogle Scholar
  12. 12.
    Leitao MM, Soslow RA, Nonaka D, et al. Tissue microarray immunohistochemical expression of estrogen, progesterone and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer. 2004;101:1455–62.CrossRefPubMedGoogle Scholar
  13. 13.
    Nordal RR, Kristensen GB, Kaern J, et al. The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma. Gynecol Oncol. 1996;62:254–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Sartori E, Bazzurini L, Gadducci A, et al. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study. Gynecol Oncol. 1997;67:70–5.CrossRefPubMedGoogle Scholar
  15. 15.
    Yamada SD, Burger RA, Brewster WR, et al. Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus. Cancer. 2000;88:2782–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Ferguson SE, Tornos C, Hummer A, et al. Prognostic features of surgical stage I uterine carcinosarcoma. Am J Surg Pathol. 2007;31:1653–61.CrossRefPubMedGoogle Scholar
  17. 17.
    Huang GS, Chiu LG, Gebb JS, et al. Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma. Gynecol Oncol. 2007;107:513–7.PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Abeler VM, Røyne O, Thoresen S, et al. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology. 2009;54:355–64.CrossRefPubMedGoogle Scholar
  19. 19.
    Gadducci A, Sartori E, Landoni F, et al. The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases. Eur J Gynaecol Oncol. 2002;23:295–9.PubMedGoogle Scholar
  20. 20.
    Koh WJ, Greer BE, Abu-Rustum NR, et al. Uterine neoplasms, version 1.2014. J Natl Compr Canc Netw. 2014;12(2):248–80.PubMedGoogle Scholar

Copyright information

© Springer India 2015

Authors and Affiliations

  1. 1.Department of Gynecologic OncologyTata Memorial HospitalMumbaiIndia
  2. 2.Department of Obstetrics and GynecologyUniversity College of Medical Sciences and Guru Teg Bahadur HospitalDelhiIndia

Personalised recommendations